Z-1050 Formula Hepatodetox Homeopathic Medicine Fails Identification Testing
Washington Homeopathic Products, Inc. is recalling Z-1050 Formula Hepatodetox 1000ml bottles because out-of-specification test results were obtained during identification testing based on HPTLC analysis.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard involves out-of-specification test results that indicate a potential quality or identity issue, but the source text does not identify a specific pathogen, allergen, or direct safety threat, nor reports any actual harm. This falls under the rubric criterion for minor labeling or quality issues in a precautionary recall context.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Z-1050 Formula Hepatodetox, a 1000ml homeopathic medicine marked "For Manufacturing Use Only" and manufactured for Optimal Health Dimensions. The recall was initiated because out-of-specification test results were obtained for identification testing based on HPTLC (high-performance thin-layer chromatography) analysis.
The affected product is distributed nationwide in the USA. The recalled lots are Lot #26071 and Lot #28180, with expiration date 8/17/2026.
Consumers or healthcare facilities that have received this product should discontinue use and contact Washington Homeopathic Products, Inc. for further instructions regarding return or disposal.
The recalled product
- Product
- Z-1050 Formula Hepatodetox. Contents 1000ml. WHP Homeopathic Medicine, For Manufacturing Use Only, REMEDY: Cholesterinum 10X, Avena Sativa 12X, Cynara Scolymos 12X, Phosphorus 12X, Oroticum Acidum 13X, Aesculus Hipposcastanum 24X, Carduus Marianus 24X, Chelidonium Majus 24X, Cimi
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic Medicine
- Hazard
- out-of-specification-test-results
- failed-identity-testing
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot # 26071
- 28180
- Exp 8/17/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27